Life sciences real estate: 2022 investment outlook

Increasing FDA approvals, including the record-breaking COVID-19 vaccines, are among the factors creating a surge in funding for the life sciences sector. Who are the market-leading managers and how to tell a manager is merely on for the ride? What kind of operational expertise does a manager need to create value in this highly specialised field and where are the next big opportunities for LPs?